{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:22:30Z","timestamp":1772612550653,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.urology.2012.09.065","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T09:33:54Z","timestamp":1363944834000},"page":"1273-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Gu\u00e9rin Therapy for Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"81","author":[{"given":"Michael J.","family":"Lipsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina M.","family":"Badalato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piruz","family":"Motamedinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg W.","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.09.065_bib1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.urology.2012.09.065_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0094-0143(03)00060-0","article-title":"Evaluation and follow-up strategies for superficial bladder cancer","volume":"30","author":"Donat","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2012.09.065_bib3","first-page":"2314","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 Update","volume":"178","author":"Hall","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib4","first-page":"1124","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.1990.tb00650.x","article-title":"Fibronectin: structure, function and significance in wound healing","volume":"31","author":"Brotchie","year":"1990","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.urology.2012.09.065_bib6","first-page":"1307","article-title":"Attachment of mycobacteria to fibronectin-coated surfaces","volume":"134","author":"Ratliff","year":"1988","journal-title":"J\u00a0Gen Microbiol"},{"key":"10.1016\/j.urology.2012.09.065_bib7","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1128\/iai.56.12.3046-3051.1988","article-title":"Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG","volume":"56","author":"Abou-Zeid","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.urology.2012.09.065_bib8","first-page":"2735","article-title":"Characterization of soluble fibronectin binding to Bacille Calmette-Guerin","volume":"135","author":"Aslanzadeh","year":"1989","journal-title":"J\u00a0Gen Microbiol"},{"key":"10.1016\/j.urology.2012.09.065_bib9","first-page":"3843","article-title":"Comparison of the fibronectin-binding ability and antitumor efficacy of various mycobacteria","volume":"50","author":"Hudson","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.09.065_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI114434","article-title":"Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response","volume":"85","author":"Kavoussi","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.urology.2012.09.065_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI116202","article-title":"Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells","volume":"91","author":"Kuroda","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.urology.2012.09.065_bib12","first-page":"3726","article-title":"Modulation of fibronectin-mediated Bacillus Calmette Gu\u00e9rin attachment to murine bladder mucosa by drugs influencing the coagulation pathways","volume":"51","author":"Hudson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.09.065_bib13","first-page":"1","article-title":"Deaths: final data for 2007","volume":"58","author":"Xu","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.urology.2012.09.065_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2012.09.065_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1464-410X.2011.10318.x","article-title":"The burden of bladder cancer in men and women: analysis of the years of life lost","volume":"109","author":"Scosyrev","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.09.065_bib16","first-page":"1362","article-title":"Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors","volume":"144","author":"Hudson","year":"1990","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000474631","article-title":"Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guerin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group","volume":"23","author":"Witjes","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1445-2197.1993.tb00060.x","article-title":"The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guerin efficacy for superficial bladder cancer","volume":"63","author":"P'Ng","year":"1993","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.urology.2012.09.065_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-410X.2008.08123.x","article-title":"Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Gu\u00e9rin","volume":"103","author":"Gee","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.09.065_bib20","first-page":"1306","article-title":"Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer","volume":"182","author":"Boorjian","year":"2009","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib21","first-page":"1762","article-title":"Intravesical Bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin","volume":"47","author":"Ratliff","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.09.065_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/00313020120083188","article-title":"Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in\u00a0vivo and in\u00a0vitro and prostaglandin E2 synthesis in cultured bladder cancer cells","volume":"33","author":"Bostrom","year":"2001","journal-title":"Pathology"},{"key":"10.1016\/j.urology.2012.09.065_bib23","first-page":"332","article-title":"Cyclooxygenase-2 inhibition: a potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"174","author":"Dovedi","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib24","first-page":"832454","article-title":"Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27","volume":"2010","author":"Xu","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.urology.2012.09.065_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2008.01.013","article-title":"Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma","volume":"54","author":"Dovedi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.09.065_bib26","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the Cross Trial Safety Analysis","volume":"117","author":"Solomon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.urology.2012.09.065_bib27","first-page":"1","article-title":"Surveillance of demographic characteristics and health behaviors among adult cancer survivors - behavioral risk factor surveillance system, United States, 2009","volume":"61","author":"Underwood","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512014811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429512014811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:56:21Z","timestamp":1758765381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429512014811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0090429512014811"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.09.065","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Gu\u00e9rin Therapy for Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2012.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}